The mechano-immunological barrier in fibrosis-associated lung cancer: targeting matrix stiffness and the Piezo1 axis for microenvironment normalization
Aug 2026· Frontiers in Pharmacology· Vol 17· 1 citation· ⚡ 1 influential· 179 references
Medicine
TL;DR
This review summarizes the Piezo1-mediated mechanotransduction networks involved in the fibrosis-to-cancer transition and discusses emerging “mechano-immunotherapeutics,” including targeted Piezo1 modulators, precision nanodelivery systems, and ECM-normalizing agents (e.g., LOX inhibitors and losartan).
Abstract
While mechanotransduction influences various lung cancer subtypes, this review focuses specifically on fibrosis-associated non-small cell lung cancer (NSCLC), where the progression from pulmonary fibrosis to malignancy is mediated by aberrant mechanotransduction. Progressive extracellular matrix (ECM) stiffening (8–25 kPa), mediated by lysyl oxidase (LOX)-dependent collagen crosslinking, establishes a “mechano-immunological barrier.” This barrier promotes malignant transformation and limits the efficacy of immunotherapy. Piezo1, a mechanically-activated cation channel, regulates this physical remodeling of the tumor microenvironment (TME). In the stiffened fibrotic stroma, mechanical tension activates Piezo1, causing intracellular Ca2+ influx. This influx bypasses canonical Hippo signaling to activate the RCC2-YAP axis and induces “epigenetic mechanical memory” via Rho/ROCK-mediated histone acetylation. Furthermore, Piezo1 modulates local immune responses. Mechanical stress activates Piezo1 in infiltrating T-cell, leading to epigenetic exhaustion and cytoskeletal impairment. Simultaneously, this mechanotransduction polarizes macrophages toward an immunosuppressive M2-like phenotype and mechanically induces PD-L1 expression on tumor cells. This review summarizes the Piezo1-mediated mechanotransduction networks involved in the fibrosis-to-cancer transition. We also discuss emerging “mechano-immunotherapeutics,” including targeted Piezo1 modulators, precision nanodelivery systems, and ECM-normalizing agents (e.g., LOX inhibitors and losartan). These strategies demonstrate synergistic effects when combined with immune checkpoint inhibitors. By softening the desmoplastic niche—a tumor-associated microenvironment characterized by excessive fibrous connective tissue and a dense ECM—and modulating mechanosensors, these interventions can convert immunosuppressive “cold” tumors into immunotherapy-responsive “hot” microenvironments.
Abstract The mechanosensitive ion channel Piezo1 translates physical cues from the tumor microenvironment—including extracellular matrix stiffness, fluid shear stress, and compressive forces—into intracellular calcium signals and downstream cascades, playing a pivotal role in cancer. Piezo1 exhibits pronounced tumor-ty...
Hai-Yan Jiang, Ying Liu, Fei Xue et al.· Drug Design, Development and...· 0 citations
It is demonstrated that PIEZO1 is substantially upregulated in fibrotic lungs, and that its activation drives intracellular calcium overload via the CISD1/IP3R signaling axis, highlighting PIEZO1 and CISD1 as promising therapeutic targets for pulmonary fibrosis.
Yun-Geng Wei, C. Xie, Xiang-Sheng Yang et al.· MedComm· 0 citations
This review systematically outlines the types and mechanotransduction mechanisms of TME mechanical signals, mechanically driven metabolic and transcriptional reprogramming, the multifaceted functions of lactylation in tumor metastasis, and the ultimate execution of the metastatic cascade driven by this positive feedbac...
Wen-Qing Zhang, Hui-Mei Chen, Jing-Ying Fan et al.· Frontiers in Immunology· 0 citations
Knee osteoarthritis (KOA) is increasingly recognized as a whole-joint mechano-inflammatory disorder in which abnormal loading, tissue remodeling, and inflammatory sensitization reinforce one another. Piezo1 is a context-dependent mechanotransduction hub that links mechanical cues to Ca
2+
-dependent inflammatory,...
Jing Li, Bo Dong, Xue-Qin Zeng et al.· Arthritis Research & The...· 0 citations
A tiered activation mechanism by which mechanical forces may trigger an initial burst of reactive oxygen species (ROS), which then leads to mitochondrial fragmentation by the action of dynamin-related protein 1 (DRP1) and ROS-induced ROS generation is described.
Tian-Li Wang, Qiang Xiao· Frontiers in Cell and Develo...· 0 citations
Pulmonary (interstitial) fibrosis, the terminal pathological stage of various interstitial lung diseases, remains a major therapeutic challenge. The three approved antifibrotic agents - pirfenidone, nintedanib, and nerandomilast - receive only moderate endorsements in current guidelines, as they decelerate rather than...
Hong Yang, Xing-Yun Hou, Li-Ya Ye et al.· Cells and Development· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.